Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in strong support of H.R. 4084, the Nuclear Energy Innovation Capabilities Act. Currently in the United States, nuclear power produces about 20 percent of our Nation's electrical supply, and that makes nuclear power the single largest carbon-free power source in the country. However, our current nuclear fleet is growing older. Many of the plants across our country are many decades old and rely upon nuclear technology that is even older. There have been substantial efforts in the past decade to move towards constructing new nuclear generating units with more modern designs. However, these efforts have had mixed results. There have been construction difficulties, regulatory hurdles, and financing issues, all of which have conspired to delay the construction of new nuclear plants in America. Some of these hurdles, though, are unlikely to go away with our current technologies. The Three Mile Island, Chernobyl, and Fukushima nuclear accidents have repeatedly highlighted the necessity of ensuring our nuclear fleet runs as safely as possible. This has led to much of the cost and difficulty of building the new plants. I think the answer to these problems can be found in innovative new nuclear technologies.…
Share & report
More from Don Beyer
Mr. Speaker, I thank the gentleman once again for staying late and for his 32 years of service just in this institution not counting all the others. Mr. Speaker, I yield to the gentlewoman from Virginia (Ms. Spanberger), a force of nature…
Mr. Speaker, I rise today to congratulate Thomas Hager Blatnik on his 37 years of service to the U.S. House of Representatives. For over 37 years, Tom worked right here in the U.S. Capitol. Shortly after graduating from Curry College, he…
Mr. Speaker, I also stand in opposition to H.R. 9495, which would provide this administration and any future administration with sweeping, unilateral authority to designate nonprofits as terror- supporting organizations and strip them of…
I have engaged with it many times. When children's Tylenol was scarce, Raul Grijalva and I led an inquiry to see if the administration could take action.





